# Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma

> **NCT00995800** · PHASE2 · COMPLETED · sponsor: **Mundipharma Research Limited** · enrollment: 46 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone propionate / Formoterol fumarate

## Key facts

- **NCT ID:** NCT00995800
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00995800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00995800, "Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00995800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*